| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.94M | 3.79M | 3.19M | 2.91M | 2.07M | 1.12M |
| Gross Profit | 452.03K | 1.36M | 943.12K | 1.14M | 946.11K | 510.33K |
| EBITDA | -2.24M | -2.90M | -2.75M | -3.80M | -3.07M | -1.08M |
| Net Income | -1.00M | -1.79M | -1.60M | -3.74M | -2.95M | -1.25M |
Balance Sheet | ||||||
| Total Assets | 3.75M | 4.30M | 4.89M | 4.73M | 5.49M | 6.57M |
| Cash, Cash Equivalents and Short-Term Investments | 755.32K | 1.42M | 1.27M | 2.62M | 2.87M | 5.74M |
| Total Debt | 521.46K | 1.12M | 112.18K | 210.74K | 275.11K | 67.60K |
| Total Liabilities | 2.88M | 3.01M | 3.28M | 1.57M | 1.41M | 665.76K |
| Stockholders Equity | 871.52K | 1.29M | 1.61M | 3.17M | 4.08M | 5.91M |
Cash Flow | ||||||
| Free Cash Flow | -1.06M | -1.95M | -1.34M | -2.98M | -3.78M | -1.11M |
| Operating Cash Flow | -914.91K | -1.81M | -1.33M | -2.97M | -3.58M | -1.08M |
| Investing Cash Flow | -157.56K | -149.02K | -8.47K | -16.00K | -229.26K | -23.71K |
| Financing Cash Flow | 104.26K | 2.08M | -10.88K | 2.74M | 939.73K | 7.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
50 Neutral | AU$15.99M | 14.23 | -135.89% | ― | -21.60% | -657.00% | |
48 Neutral | AU$18.03M | -2.43 | -684.77% | ― | 8.64% | 33.88% | |
44 Neutral | AU$13.57M | -13.39 | -123.13% | ― | 18.86% | -14.41% | |
41 Neutral | AU$5.07M | -0.39 | ― | ― | -51.64% | -21.74% | |
37 Underperform | AU$181.10M | -14.84 | ― | ― | -100.00% | 44.26% |
Audeara Limited reported a 63.76% increase in revenue to $2.95 million for the half year to 31 December 2025, while halving its loss from ordinary activities after tax to $593,443 compared with the prior corresponding period. The company’s comprehensive loss likewise narrowed by more than 57%, but net tangible asset backing per share fell to 0.45 cents from 0.81 cents, and no interim dividend was declared.
The accounts were subject to an audit review that included an emphasis of matter highlighting material uncertainty over Audeara’s ability to continue as a going concern, although the half-year report continues to be prepared on a going concern basis. The board, chaired by non-executive chair David Trimboli, noted there were no audit disputes or qualifications, underscoring that while operational performance is improving, financial sustainability and capital strength remain key concerns for stakeholders.
The most recent analyst rating on (AU:AUA) stock is a Hold with a A$0.08 price target. To see the full list of analyst forecasts on Audeara Ltd. stock, see the AU:AUA Stock Forecast page.
Audeara reported Q2 FY26 unaudited group revenue of $1.43 million, flat on the prior quarter but 274% higher than the same period a year earlier, supported by strong wholesale and technology licensing sales. Combined Q1 and Q2 FY26 revenues, together with a secured $560,000 purchase order to be recognised in Q3, now exceed $3.5 million, bringing the company close to its full FY25 revenue of $3.8 million, while the quarter delivered positive net operating cash flow of $356,000, boosted by a $1.22 million R&D tax refund, leaving $0.74 million in cash at bank at 31 December 2025. Operationally, momentum was underpinned by National Medical Products Administration certification in China for a hearing aid product, enabling commercial launch and a maiden licensing order from Eastech, a chip-level AI licensing deal with China-based SoC designer OPTEK Microelectronics, and a distribution agreement with Tokyo-based Eyear System to introduce Auracast-enabled products into Japan, collectively strengthening Audeara’s Asia-Pacific footprint and supporting its push toward recurring global licensing income and more consistent operational cash flow.
The most recent analyst rating on (AU:AUA) stock is a Hold with a A$0.06 price target. To see the full list of analyst forecasts on Audeara Ltd. stock, see the AU:AUA Stock Forecast page.
Audeara Limited announced a clarification regarding its recent chip-level AI licensing agreement with Optek Microelectronics Co., Ltd. The agreement involves licensing Audeara’s proprietary AI audio algorithms and other audio technologies, but the company confirmed that no revenue has been generated from this deal to date, nor is its financial impact currently predictable. While the agreement lacks a definitive term, Audeara views it as an opportunity to explore further collaborations with Optek. The development reflects the company’s ongoing commitment to leveraging its audio innovations within the global market.
The most recent analyst rating on (AU:AUA) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on Audeara Ltd. stock, see the AU:AUA Stock Forecast page.
Audeara Ltd. has secured a significant chip-level AI audio licensing agreement with Optek Microelectronics, a leading SoC design company in China. This deal allows Audeara’s proprietary audio processing algorithms to be integrated into Optek’s SoC platforms, expanding Audeara’s market reach by embedding its technology at the silicon level in global product platforms. The agreement is expected to be revenue-generative for Audeara on a fee-per-chip basis, enhancing its industry positioning and supporting its strategy to expand the adoption of its algorithms across global OEM and ODM partners.
The most recent analyst rating on (AU:AUA) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on Audeara Ltd. stock, see the AU:AUA Stock Forecast page.
Audeara Ltd. announced a record $560,000 purchase order from a major Australian wholesale customer, marking the largest single order to date for the company. This order boosts the company’s year-to-date Australian wholesale revenues to approximately $1.75 million, a 50% increase over the previous year. The company is also advancing its AUA Technology division, with ongoing negotiations for additional orders from global markets and the commencement of manufacturing hearing aids for the Chinese market. These developments underscore Audeara’s strengthening position in the hearing technology sector and its strategic focus on multi-channel growth through licensing and distribution partnerships.
The most recent analyst rating on (AU:AUA) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Audeara Ltd. stock, see the AU:AUA Stock Forecast page.
Audeara Limited has announced a change in the director’s interest, specifically regarding David Trimboli’s holdings. The change involves the acquisition of 954,763 ordinary fully paid shares and 1,250,000 unlisted options, which were issued as part of director fees and incentive options approved at the recent AGM. This adjustment in holdings reflects a strategic move to align director interests with company performance and shareholder value, potentially impacting the company’s governance and stakeholder confidence.
The most recent analyst rating on (AU:AUA) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Audeara Ltd. stock, see the AU:AUA Stock Forecast page.
Audeara Limited announced a change in the director’s interest notice, specifically regarding Hsin-Chieh ‘Bill’ Peng. The change involves the acquisition of 1,500,000 unlisted options expiring on December 2, 2027, at an estimated value of $25,395. This acquisition was approved as incentive options at the company’s AGM, reflecting strategic moves in director-level holdings which may influence stakeholder perceptions and company operations.
The most recent analyst rating on (AU:AUA) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Audeara Ltd. stock, see the AU:AUA Stock Forecast page.
Audeara Limited has issued 954,763 shares at an issue price of $0.028, following approval at the recent Annual General Meeting. This move aligns with the company’s compliance with relevant corporate regulations and indicates no undisclosed information that could affect investor assessments. The issuance is part of Audeara’s ongoing efforts to strengthen its market position and enhance shareholder value.
The most recent analyst rating on (AU:AUA) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Audeara Ltd. stock, see the AU:AUA Stock Forecast page.
Audeara Ltd. announced the issuance of 4,250,000 unlisted options, set to expire on December 2, 2027, with an exercise price of $0.05. This move is part of previously announced transactions and reflects the company’s strategic efforts to enhance its financial flexibility and operational capabilities, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (AU:AUA) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Audeara Ltd. stock, see the AU:AUA Stock Forecast page.